Fig. 1From: Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experienceJIA activity by JADAS-10 score before and after vaccination revealing no flare of the primary disease after vaccinationBack to article page